Generated by AI
Fresenius Medical Care AG - Depositary Receipt is the U.S.-traded American Depositary Receipt for Fresenius Medical Care, a global healthcare company focused on renal care. Fresenius Medical Care provides dialysis products and related services for people with chronic kidney disease, supporting treatment across hospitals, clinics, and home-based care settings. Its business is organized around care delivery and care enablement, combining clinical services with the development, manufacturing, and supply of dialysis equipment, consumables, and associated technologies. The company serves healthcare providers and patients in the United States, Europe, and other international markets, making it an important participant in the kidney care ecosystem. As a depositary receipt, it offers a U.S. listing structure for investors seeking exposure to Fresenius Medical Care’s healthcare operations without directly referencing the underlying foreign share.
WebsiteElse-Kröner-Strasse 1
Bad Homburg, 61352
Germany
The latest articles about FMS.
Fresenius Medical Care (FMS) stock gains as parent Fresenius SE (FSNUF) (FSNUY) cuts its stake to ~20% from ~25%. Read more here.
Summary of Oct 7's posts. Generated by AI.
Summary of Nov 2's posts. Generated by AI.
Summary of Dec 22's posts. Generated by AI.
Summary of May 22's posts. Generated by AI.
Investors talking about FMS also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.